Emerging Molecularly Defined Bone and Soft Tissue Diagnoses: When Do They Matter?
1/5 보강
With the rapid advancement of molecular pathology and the explosion of genomic data, our understanding of neoplasms continues to evolve.
APA
Davis JL, Samiei A (2026). Emerging Molecularly Defined Bone and Soft Tissue Diagnoses: When Do They Matter?. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 39(4), 100981. https://doi.org/10.1016/j.modpat.2026.100981
MLA
Davis JL, et al.. "Emerging Molecularly Defined Bone and Soft Tissue Diagnoses: When Do They Matter?." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, vol. 39, no. 4, 2026, pp. 100981.
PMID
41759784 ↗
Abstract 한글 요약
With the rapid advancement of molecular pathology and the explosion of genomic data, our understanding of neoplasms continues to evolve. In this review, we introduce 3 recently classified mesenchymal neoplasms, the categorization of which was refined based on their underlying molecular genetic profiles. These entities were recently highlighted by the senior author at the United States and Canadian Academy of Pathology Long Course. To underscore the importance of their proper recognition, this review was prepared to reach a broader audience. Recognition of these tumors is particularly important because their mimickers often have markedly disparate prognoses and management strategies, making accurate diagnosis critical. The 3 entities discussed in this study are the following: (1) SRF-rearranged myoid neoplasms (formerly cellular myofibroma), (2) superficial CD34-positive fibroblastic tumors, and (3) kinase-altered spindle cell neoplasms. This review aimed to highlight the key clinicopathologic features of these tumors to facilitate accurate diagnosis, discuss ancillary studies that assist in navigating the differential diagnoses, and outline strategies to avoid common diagnostic pitfalls. Finally, we emphasize when molecular characterization may be necessary to guide diagnosis and support appropriate clinical management.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.